TY - JOUR
T1 - New morbidity and discharge disposition of pediatric acute respiratory distress syndrome survivors
AU - Keim, Garrett
AU - Scott Watson, R.
AU - Thomas, Neal J.
AU - Yehya, Nadir
N1 - Funding Information:
Supported, in part, by grants from the National Institutes of Health K12-HL109009 and K23-HL136688 (to Dr. Yehya).*%blankline%*
Funding Information:
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal). Supported, in part, by grants from the National Institutes of Health K12-HL109009 and K23-HL136688 (to Dr. Yehya). Dr. Keim received support for article research from the National Institutes Pediatric acute respiratory distress syndrome (PARDS) CareFusion and grants from the Federal Drug Association, all outside of theof Health (NIH). Dr. Thomas reports personal fees from Therabron and causes significant disease burden in PICUs with a reported submitted work. Dr. Thomas’ institution received funding from GeneFluid- prevalence of close to 2% (1) and short-term mortality ics, and he received funding from CareFusion and Therabron. Dr. Yehya’s rates up to 20% (2). In order to better standardize diagnosis, the Institute, and he received support for article research from the NIH. Dr. Wat-institution received funding from the NIH/National Heart, Lung, and Blood Pediatric Acute Lung Injury Consensus Conference (PALICC) son has disclosed that he does not have any potential conflicts of interest. published diagnostic guidelines in 2015 (3). Recent publications For information regarding this article, E-mail: keimg@email.chop.edu have focused on characterizing severity of disease and identify-Copyright © 2018 by the Society of Critical Care Medicine and Wolters ing predictors of short-term mortality (4, 5). Kluwer Health, Inc. All Rights Reserved. With improving survival after adult acute respiratory dis- DOI: 10.1097/CCM.0000000000003341 tress syndrome (ARDS), long-term outcome studies have
Publisher Copyright:
© 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
PY - 2018
Y1 - 2018
N2 - Objectives: Much of the research related to pediatric acute respiratory distress syndrome has focused on inhospital mortality and interventions affecting this outcome. Limited data exist on survivors' morbidity, hospital disposition, and 1-year survival. The aim of this study was to determine new morbidity rate, discharge disposition, and 1-year mortality for survivors of pediatric acute respiratory distress syndrome. Design: Secondary analysis of prospective cohort study. Setting: Quaternary children's hospital. Patients: Three-hundred sixteen mechanically ventilated children with pediatric acute respiratory distress syndrome (Berlin and Pediatric Acute Lung Injury Consensus Conference criteria) between July 2011 and December 2014. Interventions: None. Measurements and Main Results: We performed secondary analysis of a prospectively recruited cohort of 316 mechanically ventilated children with pediatric acute respiratory distress syndrome between July 2011, and December 2014. Preillness and hospital discharge Functional Status Scale score were determined via chart review, and factors associated with new morbidity, defned as an increase of Functional Status Scale score of 3 or more, were analyzed. Demographic variables, pediatric acute respiratory distress syndrome characteristics, and ventilator management were tested for association with development of new morbidity, discharge disposition, and 1-year mortality. Inhospital mortality of pediatric acute respiratory distress syndrome was 13.3% (42/316). Of 274 survivors to hospital discharge, new morbidity was seen in 63 patients (23%). Discharge to rehabilitation rate was 24.5% (67/274) and associated with development of new morbidity. One-and 3-year mortality of survivors was 5.5% (15 deaths) and 8% (22 deaths) and was associated with baseline Functional Status Scale, immunocompromised status, Pediatric Risk of Mortality III, and organ failures at pediatric acute respiratory distress syndrome onset, but not with pediatric acute respiratory distress syndrome severity. Conclusions: New morbidity was common after pediatric acute respiratory distress syndrome and appears to be intermediate phenotype between survival without morbidity and death, making it a useful metric in future interventional and outcome studies in pediatric acute respiratory distress syndrome.
AB - Objectives: Much of the research related to pediatric acute respiratory distress syndrome has focused on inhospital mortality and interventions affecting this outcome. Limited data exist on survivors' morbidity, hospital disposition, and 1-year survival. The aim of this study was to determine new morbidity rate, discharge disposition, and 1-year mortality for survivors of pediatric acute respiratory distress syndrome. Design: Secondary analysis of prospective cohort study. Setting: Quaternary children's hospital. Patients: Three-hundred sixteen mechanically ventilated children with pediatric acute respiratory distress syndrome (Berlin and Pediatric Acute Lung Injury Consensus Conference criteria) between July 2011 and December 2014. Interventions: None. Measurements and Main Results: We performed secondary analysis of a prospectively recruited cohort of 316 mechanically ventilated children with pediatric acute respiratory distress syndrome between July 2011, and December 2014. Preillness and hospital discharge Functional Status Scale score were determined via chart review, and factors associated with new morbidity, defned as an increase of Functional Status Scale score of 3 or more, were analyzed. Demographic variables, pediatric acute respiratory distress syndrome characteristics, and ventilator management were tested for association with development of new morbidity, discharge disposition, and 1-year mortality. Inhospital mortality of pediatric acute respiratory distress syndrome was 13.3% (42/316). Of 274 survivors to hospital discharge, new morbidity was seen in 63 patients (23%). Discharge to rehabilitation rate was 24.5% (67/274) and associated with development of new morbidity. One-and 3-year mortality of survivors was 5.5% (15 deaths) and 8% (22 deaths) and was associated with baseline Functional Status Scale, immunocompromised status, Pediatric Risk of Mortality III, and organ failures at pediatric acute respiratory distress syndrome onset, but not with pediatric acute respiratory distress syndrome severity. Conclusions: New morbidity was common after pediatric acute respiratory distress syndrome and appears to be intermediate phenotype between survival without morbidity and death, making it a useful metric in future interventional and outcome studies in pediatric acute respiratory distress syndrome.
UR - http://www.scopus.com/inward/record.url?scp=85054896958&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054896958&partnerID=8YFLogxK
U2 - 10.1097/CCM.0000000000003341
DO - 10.1097/CCM.0000000000003341
M3 - Article
C2 - 30024428
AN - SCOPUS:85054896958
SN - 0090-3493
VL - 46
SP - 1731
EP - 1738
JO - Critical Care Medicine
JF - Critical Care Medicine
IS - 11
ER -